NBCA Survey Shows Gaps in DVT/PE Prophylaxis Among Hospitalized Patients
Data Demonstrate Patient Awareness is Low, Despite Increased Risks
Data from NBCA’s online survey of 500 patients who
had been hospitalized for >3 days, show that less than one-third of
respondents report DVT prophylaxis with either an anticoagulant pill or
anticoagulant injection, even though more than 40% of them report that they
had a family member who previously had a blood clot in the leg or lung, and
15% say they had a personal history of a blood clot in the leg or lung. DVT
prophylaxis reported by respondents include: 63% ambulation, 39%
compression stockings, 37% mechanical compression, 37% aspirin, 29%
anticoagulant injection, and 28% anticoagulant pill. These survey findings
are compelling, because they demonstrate the gaps that need to be filled to
optimize use of evidence-based DVT/PE prophylaxis, as well as the need to
better inform or educate our hospitalized patients about potential risk
factors.
Risk Versus Awareness - Read More...
General Public Vs. At-Risk Oncology
and Hospitalized Samples - Read More...
Hospital Findings Quick Facts - Read
More...
Survey Methodology - Read More...
The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
